Sophia Abner

1.5k total citations · 1 hit paper
18 papers, 945 citations indexed

About

Sophia Abner is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Sophia Abner has authored 18 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Sophia Abner's work include Chronic Disease Management Strategies (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Muscle Physiology and Disorders (4 papers). Sophia Abner is often cited by papers focused on Chronic Disease Management Strategies (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Muscle Physiology and Disorders (4 papers). Sophia Abner collaborates with scholars based in United Kingdom, United States and Germany. Sophia Abner's co-authors include Clare Gillies, Kamlesh Khunti, Melanie J. Davies, Elpida Vounzoulaki, Bee K. Tan, A. Farooqi, Samuel Seidu, Richard Morriss, Harini Sathanapally and William H. Polonsky and has published in prestigious journals such as Neurology, BMJ and Diabetes Obesity and Metabolism.

In The Last Decade

Sophia Abner

17 papers receiving 927 citations

Hit Papers

Progression to type 2 diabetes in women with a known hist... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophia Abner United Kingdom 7 618 268 259 232 127 18 945
Ingrid Östlund Sweden 18 862 1.4× 343 1.3× 133 0.5× 456 2.0× 78 0.6× 25 1.1k
Leishen Wang China 19 669 1.1× 288 1.1× 125 0.5× 373 1.6× 74 0.6× 65 991
Beata Stach‐Lempinen Finland 18 724 1.2× 398 1.5× 75 0.3× 304 1.3× 82 0.6× 40 965
Nanna Voldner Norway 19 910 1.5× 220 0.8× 83 0.3× 500 2.2× 63 0.5× 32 1.2k
Fredrik Ahlsson Sweden 19 410 0.7× 101 0.4× 124 0.5× 660 2.8× 110 0.9× 71 1.1k
Mary Rosser United States 10 265 0.4× 97 0.4× 70 0.3× 232 1.0× 70 0.6× 23 679
C. Ben Slama Tunisia 16 171 0.3× 120 0.4× 273 1.1× 119 0.5× 135 1.1× 48 868
Miwa Takayanagi United States 9 146 0.2× 211 0.8× 60 0.2× 78 0.3× 92 0.7× 9 477
Deepiksana Keerthy United Kingdom 8 192 0.3× 108 0.4× 127 0.5× 86 0.4× 28 0.2× 9 417

Countries citing papers authored by Sophia Abner

Since Specialization
Citations

This map shows the geographic impact of Sophia Abner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophia Abner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophia Abner more than expected).

Fields of papers citing papers by Sophia Abner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophia Abner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophia Abner. The network helps show where Sophia Abner may publish in the future.

Co-authorship network of co-authors of Sophia Abner

This figure shows the co-authorship network connecting the top 25 collaborators of Sophia Abner. A scholar is included among the top collaborators of Sophia Abner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophia Abner. Sophia Abner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Landfeldt, Erik, Sophia Abner, Rongrong Zhang, et al.. (2024). Predictors of cardiac disease in duchenne muscular dystrophy: a systematic review and evidence grading. Orphanet Journal of Rare Diseases. 19(1). 359–359. 3 indexed citations
2.
Landfeldt, Erik, Alicia Alemán, Sophia Abner, et al.. (2024). Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis. Journal of Neuromuscular Diseases. 11(3). 579–612. 6 indexed citations
4.
Landfeldt, Erik, Farasat Zaman, Sophia Abner, et al.. (2023). Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy. Neurology. 102(2). e207948–e207948. 4 indexed citations
5.
Landfeldt, Erik, Alicia Alemán, Sophia Abner, et al.. (2023). Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading. Journal of Neuromuscular Diseases. 11(1). 25–57. 3 indexed citations
6.
Landfeldt, Erik, Simone Thiele, Maggie C. Walter, et al.. (2023). Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany. Orphanet Journal of Rare Diseases. 18(1). 32–32. 6 indexed citations
7.
Shabnam, Sharmin, Sophia Abner, Francesco Zaccardi, et al.. (2023). Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(6). 102782–102782. 6 indexed citations
8.
Landfeldt, Erik, Simone Thiele, Sophia Abner, et al.. (2023). Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany. Journal of Neuromuscular Diseases. 11(1). 117–128. 5 indexed citations
9.
Shabnam, Sharmin, Sophia Abner, Clare Gillies, et al.. (2023). Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study. Diabetes Obesity and Metabolism. 26(2). 512–523. 1 indexed citations
10.
Abner, Sophia, Clare Gillies, Sharmin Shabnam, et al.. (2022). Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England. Cardiovascular Diabetology. 21(1). 8–8. 6 indexed citations
11.
Abner, Sophia, Briana Coles, Claire Lawson, et al.. (2022). Ethnicity and prognosis following a cardiovascular event in people with and without type 2 diabetes: Observational analysis in over 5 million subjects in England. Diabetes Research and Clinical Practice. 189. 109967–109967. 4 indexed citations
12.
Routen, Ash, Sophia Abner, Louis S Levene, et al.. (2022). Variations in documentation of atrial fibrillation predicted by population and service level characteristics in primary health care in England. Journal of Public Health. 45(1). 57–65.
13.
Landfeldt, Erik, Sophia Abner, Astrid Pechmann, et al.. (2022). Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review. PharmacoEconomics. 41(3). 275–293. 14 indexed citations
14.
Farooqi, A., Clare Gillies, Harini Sathanapally, et al.. (2021). A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes. Primary care diabetes. 16(1). 1–10. 96 indexed citations
15.
Vounzoulaki, Elpida, Kamlesh Khunti, Sophia Abner, et al.. (2020). Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 369. m1361–m1361. 688 indexed citations breakdown →
16.
Vounzoulaki, Elpida, Kamlesh Khunti, Sophia Abner, et al.. (2020). Progression to Type 2 Diabetes in Women With a Known History of Gestational Diabetes: Systematic Review and Meta-analysis. Obstetrical & Gynecological Survey. 75(10). 589–591. 26 indexed citations
17.
Farooqi, A., Kamlesh Khunti, Sophia Abner, et al.. (2019). Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 156. 107816–107816. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026